ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
62.882,63
-1,34%
Brent Oil
88,165
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Qiagen NV (QGEN)

  7. Qiagen NV (QGEN) Notícias

QGEN

Qiagen NV (QGEN)

Qiagen NV
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:QGEN
DataHoraFonteTítuloCódigoCompanhia
24/04/202417:05GlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
09/04/202410:48GlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
03/04/202417:05GlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
25/03/202417:05GlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
18/03/202417:05GlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
11/03/202406:59GlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
27/02/202419:44GlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
27/02/202418:05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
08/02/202411:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
06/02/202418:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
25/01/202412:00GlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
23/01/202418:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
18/01/202418:05GlobeNewswire Inc.QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 millionNYSE:QGENQiagen NV
11/01/202409:53GlobeNewswire Inc.QIAGEN N.V. to release results for Q4 2023 and hold webcastNYSE:QGENQiagen NV
08/01/202404:00GlobeNewswire Inc.QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular SystemsNYSE:QGENQiagen NV
07/01/202415:07GlobeNewswire Inc.QIAGEN announces plans to return approximately $300 million to shareholdersNYSE:QGENQiagen NV
04/01/202418:05GlobeNewswire Inc.QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics businessNYSE:QGENQiagen NV
03/01/202404:00GlobeNewswire Inc.QIAGEN expands business in Middle East with new regional headquarters and major projectsNYSE:QGENQiagen NV
30/11/202318:05GlobeNewswire Inc.DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogyNYSE:QGENQiagen NV
15/11/202318:05GlobeNewswire Inc.QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationNYSE:QGENQiagen NV
09/11/202318:05GlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customersNYSE:QGENQiagen NV
06/11/202318:05GlobeNewswire Inc.QIAGEN launches complete Sample to Insight workflow for microbiome researchNYSE:QGENQiagen NV
02/11/202309:00GlobeNewswire Inc.QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
30/10/202317:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CERNYSE:QGENQiagen NV
26/10/202309:00GlobeNewswire Inc.QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancerNYSE:QGENQiagen NV
09/10/202312:14GlobeNewswire Inc.QIAGEN N.V. to release results for Q3 2023 and hold webcastNYSE:QGENQiagen NV
04/10/202317:05GlobeNewswire Inc.QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virusNYSE:QGENQiagen NV
28/09/202317:05GlobeNewswire Inc.QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completenessNYSE:QGENQiagen NV
27/09/202317:05GlobeNewswire Inc.QIAGEN reports progress toward achieving Environmental, Social and Governance goals in 2022 Sustainability ReportNYSE:QGENQiagen NV
25/09/202317:05GlobeNewswire Inc.QIAGEN enhances QIAwave portfolio with new eco-friendlier nucleic acid extraction kitsNYSE:QGENQiagen NV
 Apresentando as notícias mais relevantes sobre:NYSE:QGEN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
OIBR3
OI ON
BOV
PRIO3
PETRORIO ON
BOV
PDGR3
PDG REALT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados